{"id": "article-96178_0", "title": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- Continuing Education Activity", "content": "SARS-CoV-2, a novel enveloped, positive single-stranded RNA beta coronavirus, is the causative agent behind COVID-19. Amid the myriad symptoms associated with this disease, suspected ocular manifestations have garnered attention, leading to investigations into ocular signs, symptoms, and potential transmission routes. While direct contact with mucous membranes, including the eye, is thought to be a possible transmission route, conclusive evidence remains elusive. Complicating matters further, several reports have emerged suggesting that ocular manifestations\u00a0may be the sole indicator of COVID-19 illness in certain patients, underscoring the importance of vigilant ocular assessment in the diagnostic process.", "contents": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- Continuing Education Activity. SARS-CoV-2, a novel enveloped, positive single-stranded RNA beta coronavirus, is the causative agent behind COVID-19. Amid the myriad symptoms associated with this disease, suspected ocular manifestations have garnered attention, leading to investigations into ocular signs, symptoms, and potential transmission routes. While direct contact with mucous membranes, including the eye, is thought to be a possible transmission route, conclusive evidence remains elusive. Complicating matters further, several reports have emerged suggesting that ocular manifestations\u00a0may be the sole indicator of COVID-19 illness in certain patients, underscoring the importance of vigilant ocular assessment in the diagnostic process."}
{"id": "article-96178_1", "title": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- Continuing Education Activity", "content": "This activity delves into evaluating and managing ocular manifestations observed in COVID-19 cases. It aims to elucidate the diverse range of ocular signs and symptoms associated with the disease, offering insights into their clinical significance and implications for patient care. Furthermore, this activity highlights the pivotal role of the interprofessional healthcare team in effectively managing patients presenting with ocular manifestations of COVID-19, emphasizing the collaborative efforts required for optimal patient outcomes in this evolving clinical landscape.", "contents": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- Continuing Education Activity. This activity delves into evaluating and managing ocular manifestations observed in COVID-19 cases. It aims to elucidate the diverse range of ocular signs and symptoms associated with the disease, offering insights into their clinical significance and implications for patient care. Furthermore, this activity highlights the pivotal role of the interprofessional healthcare team in effectively managing patients presenting with ocular manifestations of COVID-19, emphasizing the collaborative efforts required for optimal patient outcomes in this evolving clinical landscape."}
{"id": "article-96178_2", "title": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- Continuing Education Activity", "content": "Objectives: Screen patients during routine clinical encounters for ocular symptoms suggestive of COVID-19 to aid in early detection and prevention of disease transmission. Implement appropriate infection control measures in ophthalmic settings to mitigate the risk of COVID-19 transmission via ocular secretions. Apply evidence-based guidelines for evaluating and managing ocular manifestations in patients with suspected or confirmed COVID-19. Coordinate care and follow-up for COVID-19 patients with ocular symptoms to optimize outcomes and minimize disease spread within the community. Access free multiple choice questions on this topic.", "contents": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- Continuing Education Activity. Objectives: Screen patients during routine clinical encounters for ocular symptoms suggestive of COVID-19 to aid in early detection and prevention of disease transmission. Implement appropriate infection control measures in ophthalmic settings to mitigate the risk of COVID-19 transmission via ocular secretions. Apply evidence-based guidelines for evaluating and managing ocular manifestations in patients with suspected or confirmed COVID-19. Coordinate care and follow-up for COVID-19 patients with ocular symptoms to optimize outcomes and minimize disease spread within the community. Access free multiple choice questions on this topic."}
{"id": "article-96178_3", "title": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- Introduction", "content": "Beginning in December 2019, COVID-19 developed into\u00a0a global pandemic caused by the highly transmissible SARS-CoV-2. [1] Numerous anecdotal and published reports initially indicated eye redness and irritation in patients with COVID-19,\u00a0supporting conjunctivitis as an ocular manifestation of SARS-CoV-2 infection. Ongoing reports\u00a0reveal associations between\u00a0COVID-19\u00a0and uveitic, retinovascular, and neuro-ophthalmic disease.", "contents": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- Introduction. Beginning in December 2019, COVID-19 developed into\u00a0a global pandemic caused by the highly transmissible SARS-CoV-2. [1] Numerous anecdotal and published reports initially indicated eye redness and irritation in patients with COVID-19,\u00a0supporting conjunctivitis as an ocular manifestation of SARS-CoV-2 infection. Ongoing reports\u00a0reveal associations between\u00a0COVID-19\u00a0and uveitic, retinovascular, and neuro-ophthalmic disease."}
{"id": "article-96178_4", "title": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- Introduction", "content": "During the 2003 severe acute respiratory\u00a0syndrome (SARS) outbreak, a study identified SARS-CoV in tear samples\u00a0collected in Singapore from patients with SARS. [2] The absence of eye protection\u00a0emerged as a primary risk factor for SARS-CoV transmission from patients to healthcare workers in Toronto,\u00a0raising concerns\u00a0about the potential for respiratory illnesses to be transmitted through ocular secretions. [3] [4] Similar concerns have been\u00a0expressed\u00a0regarding SARS-CoV-2,\u00a0particularly among eye care providers and frontline personnel responsible for assessing patients with the potential initial symptoms of COVID-19.", "contents": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- Introduction. During the 2003 severe acute respiratory\u00a0syndrome (SARS) outbreak, a study identified SARS-CoV in tear samples\u00a0collected in Singapore from patients with SARS. [2] The absence of eye protection\u00a0emerged as a primary risk factor for SARS-CoV transmission from patients to healthcare workers in Toronto,\u00a0raising concerns\u00a0about the potential for respiratory illnesses to be transmitted through ocular secretions. [3] [4] Similar concerns have been\u00a0expressed\u00a0regarding SARS-CoV-2,\u00a0particularly among eye care providers and frontline personnel responsible for assessing patients with the potential initial symptoms of COVID-19."}
{"id": "article-96178_5", "title": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- Introduction", "content": "Dr Li Wenliang, an opthalmologist, was among the first to express apprehensions about the coronavirus transmission in Chinese patients. Unfortunately, he succumbed to COVID-19, and it was suspected that he contracted the virus from an asymptomatic glaucoma patient in his clinic. [5]", "contents": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- Introduction. Dr Li Wenliang, an opthalmologist, was among the first to express apprehensions about the coronavirus transmission in Chinese patients. Unfortunately, he succumbed to COVID-19, and it was suspected that he contracted the virus from an asymptomatic glaucoma patient in his clinic. [5]"}
{"id": "article-96178_6", "title": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- Etiology", "content": "SARS-CoV-2 is an enveloped, positive single-stranded RNA beta coronavirus responsible for causing COVID-19 (see Image. Structure of COVID-19). It was initially associated\u00a0with an outbreak in Wuhan, located in China's Hubei province. [1] Direct contact with mucous membranes, including the eye, is a suspected transmission route.", "contents": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- Etiology. SARS-CoV-2 is an enveloped, positive single-stranded RNA beta coronavirus responsible for causing COVID-19 (see Image. Structure of COVID-19). It was initially associated\u00a0with an outbreak in Wuhan, located in China's Hubei province. [1] Direct contact with mucous membranes, including the eye, is a suspected transmission route."}
{"id": "article-96178_7", "title": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- Etiology", "content": "Coronaviruses\u00a0have been known to\u00a0cause severe ocular diseases in animals,\u00a0leading to anterior uveitis, retinitis, vasculitis, and optic neuritis in feline and murine species. In contrast, ocular manifestations in humans are typically mild and rare,\u00a0although there\u00a0is a growing\u00a0number of\u00a0reported ocular findings in\u00a0individuals who test positive for COVID-19. [6]", "contents": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- Etiology. Coronaviruses\u00a0have been known to\u00a0cause severe ocular diseases in animals,\u00a0leading to anterior uveitis, retinitis, vasculitis, and optic neuritis in feline and murine species. In contrast, ocular manifestations in humans are typically mild and rare,\u00a0although there\u00a0is a growing\u00a0number of\u00a0reported ocular findings in\u00a0individuals who test positive for COVID-19. [6]"}
{"id": "article-96178_8", "title": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- Etiology", "content": "No ocular manifestations of Middle East respiratory syndrome (MERS) or SARS have been reported. However, as\u00a0mentioned\u00a0earlier, SARS-CoV was identified in ocular secretions. [2] Other coronaviruses have been found to cause viral conjunctivitis in humans. [7]", "contents": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- Etiology. No ocular manifestations of Middle East respiratory syndrome (MERS) or SARS have been reported. However, as\u00a0mentioned\u00a0earlier, SARS-CoV was identified in ocular secretions. [2] Other coronaviruses have been found to cause viral conjunctivitis in humans. [7]"}
{"id": "article-96178_9", "title": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- Epidemiology", "content": "As of April 4, 2020,\u00a0the World Health Organization (WHO) reported\u00a01,272,953\u00a0confirmed cases and 69,428\u00a0deaths worldwide due to COVID-19, with an additional 79,332 new cases confirmed in the preceding\u00a024 hours. Meanwhile, the Centers for Disease Control and Prevention (CDC) had documented 337,278 cases and 9637 deaths in the United States up to that date.", "contents": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- Epidemiology. As of April 4, 2020,\u00a0the World Health Organization (WHO) reported\u00a01,272,953\u00a0confirmed cases and 69,428\u00a0deaths worldwide due to COVID-19, with an additional 79,332 new cases confirmed in the preceding\u00a024 hours. Meanwhile, the Centers for Disease Control and Prevention (CDC) had documented 337,278 cases and 9637 deaths in the United States up to that date."}
{"id": "article-96178_10", "title": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- Epidemiology", "content": "On April 16, 2021,\u00a0slightly over a year later, the global death toll surpassed the 3 million mark. The\u00a0gravity of the pandemic is\u00a0underscored by noting the rate of fatalities: it took 8.5 months\u00a0from the first fatality in China to reach the initial 1 million lives lost, 3.5 months to reach 2 million, and just\u00a03 months\u00a0to exceed the 3 million lives lost milestone.", "contents": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- Epidemiology. On April 16, 2021,\u00a0slightly over a year later, the global death toll surpassed the 3 million mark. The\u00a0gravity of the pandemic is\u00a0underscored by noting the rate of fatalities: it took 8.5 months\u00a0from the first fatality in China to reach the initial 1 million lives lost, 3.5 months to reach 2 million, and just\u00a03 months\u00a0to exceed the 3 million lives lost milestone."}
{"id": "article-96178_11", "title": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- Epidemiology", "content": "As of December 23, 2021, the US has reported 51,574,787 confirmed cases of COVID-19 and 809,300 deaths. Globally,\u00a0the WHO has documented over\u00a0276 million confirmed cases and 5,374,744 deaths due to COVID-19. Additionally, 8,649,057,088 vaccine doses have been administered worldwide by that date. The United States leads in the number of infections, followed by India, Brazil, the United Kingdom, Russia, Turkey, and France.", "contents": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- Epidemiology. As of December 23, 2021, the US has reported 51,574,787 confirmed cases of COVID-19 and 809,300 deaths. Globally,\u00a0the WHO has documented over\u00a0276 million confirmed cases and 5,374,744 deaths due to COVID-19. Additionally, 8,649,057,088 vaccine doses have been administered worldwide by that date. The United States leads in the number of infections, followed by India, Brazil, the United Kingdom, Russia, Turkey, and France."}
{"id": "article-96178_12", "title": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- Epidemiology", "content": "Viral mutations leading to variants of SARS-CoV-2 have been\u00a0identified globally, including the B.1.1.7 variant in the United Kingdom in early 2020, the B.1.526 variant in the United States in November 2020, the B.1.525 variant in the United Kingdom and Nigeria in December 2020, and the B.1.351 variant in South Africa in late 2020. The Delta variant, B.1.617.2, was\u00a0first identified in India in December 2020 and rapidly spread\u00a0across over 60 countries due to a 40% to 60% increase in transmissibility, becoming the predominant strain\u00a0worldwide by August 2021. [8] Most recently, the Omicron variant, B.1.1.529, was\u00a0designated a variant of concern in late November 2021\u00a0following cases that emerged from Botswana and South Africa, showing rapid and exponential spread. [9]", "contents": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- Epidemiology. Viral mutations leading to variants of SARS-CoV-2 have been\u00a0identified globally, including the B.1.1.7 variant in the United Kingdom in early 2020, the B.1.526 variant in the United States in November 2020, the B.1.525 variant in the United Kingdom and Nigeria in December 2020, and the B.1.351 variant in South Africa in late 2020. The Delta variant, B.1.617.2, was\u00a0first identified in India in December 2020 and rapidly spread\u00a0across over 60 countries due to a 40% to 60% increase in transmissibility, becoming the predominant strain\u00a0worldwide by August 2021. [8] Most recently, the Omicron variant, B.1.1.529, was\u00a0designated a variant of concern in late November 2021\u00a0following cases that emerged from Botswana and South Africa, showing rapid and exponential spread. [9]"}
{"id": "article-96178_13", "title": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- Epidemiology", "content": "Initial\u00a0studies postulated that ocular manifestations of COVID-19 were infrequent. Only 9 (0.8%) out of 1099 patients from 552 hospitals across 30 provinces in China were reported to\u00a0exhibit conjunctival congestion from December 2019 through January 2020. [10] Recent data, however, indicate a\u00a0significantly higher incidence of ocular signs and symptoms. A 2021 meta-analysis by Nasiri et al reported a pooled prevalence of all ocular manifestations among 7300 COVID-19 patients as 11.03%, with conjunctivitis being the most frequent ocular disease (88.8%). [11] In the same meta-analysis, other common symptoms included dry eye or foreign body sensation (16%), eye redness (13.3%), tearing (12.8%), and itching (12.6%).", "contents": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- Epidemiology. Initial\u00a0studies postulated that ocular manifestations of COVID-19 were infrequent. Only 9 (0.8%) out of 1099 patients from 552 hospitals across 30 provinces in China were reported to\u00a0exhibit conjunctival congestion from December 2019 through January 2020. [10] Recent data, however, indicate a\u00a0significantly higher incidence of ocular signs and symptoms. A 2021 meta-analysis by Nasiri et al reported a pooled prevalence of all ocular manifestations among 7300 COVID-19 patients as 11.03%, with conjunctivitis being the most frequent ocular disease (88.8%). [11] In the same meta-analysis, other common symptoms included dry eye or foreign body sensation (16%), eye redness (13.3%), tearing (12.8%), and itching (12.6%)."}
{"id": "article-96178_14", "title": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- Epidemiology", "content": "In a case series involving 38 hospitalized patients with COVID-19 in Hubei province, China,\u00a0 ocular symptoms\u00a0were reported in 12 individuals (31.6%). [12] These patients\u00a0exhibited conjunctival hyperemia (3 patients), chemosis (7 patients), epiphora (7 patients), or increased secretions (7 patients). Notably, only 1\u00a0patient presented with epiphora as the\u00a0initial symptom of COVID-19.\u00a0Among those with ocular manifestations, 2 patients (16.7%)\u00a0tested positive\u00a0for SARS-CoV-2\u00a0through reverse-transcriptase polymerase chain reaction (RT-PCR) using a conjunctival swab and nasopharyngeal swabs. Only\u00a01 patient in\u00a0the study presented with conjunctivitis as the first symptom. [12] The authors\u00a0observed that patients with ocular symptoms had higher white blood cell and neutrophil counts, C-reactive protein, and\u00a0elevated levels of procalcitonin and lactate dehydrogenase than patients without ocular abnormalities.", "contents": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- Epidemiology. In a case series involving 38 hospitalized patients with COVID-19 in Hubei province, China,\u00a0 ocular symptoms\u00a0were reported in 12 individuals (31.6%). [12] These patients\u00a0exhibited conjunctival hyperemia (3 patients), chemosis (7 patients), epiphora (7 patients), or increased secretions (7 patients). Notably, only 1\u00a0patient presented with epiphora as the\u00a0initial symptom of COVID-19.\u00a0Among those with ocular manifestations, 2 patients (16.7%)\u00a0tested positive\u00a0for SARS-CoV-2\u00a0through reverse-transcriptase polymerase chain reaction (RT-PCR) using a conjunctival swab and nasopharyngeal swabs. Only\u00a01 patient in\u00a0the study presented with conjunctivitis as the first symptom. [12] The authors\u00a0observed that patients with ocular symptoms had higher white blood cell and neutrophil counts, C-reactive protein, and\u00a0elevated levels of procalcitonin and lactate dehydrogenase than patients without ocular abnormalities."}
{"id": "article-96178_15", "title": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- Epidemiology", "content": "In a study by Xia et al involving 30 hospitalized patients with COVID-19, 1 patient tested positive for SARS-CoV-2 in ocular secretions\u00a0through a conjunctival swab. This patient did not\u00a0present\u00a0with\u00a0severe fever or respiratory symptoms during testing. [13]", "contents": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- Epidemiology. In a study by Xia et al involving 30 hospitalized patients with COVID-19, 1 patient tested positive for SARS-CoV-2 in ocular secretions\u00a0through a conjunctival swab. This patient did not\u00a0present\u00a0with\u00a0severe fever or respiratory symptoms during testing. [13]"}
{"id": "article-96178_16", "title": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- Epidemiology", "content": "Among ocular manifestations of the disease, conjunctivitis and keratoconjunctivitis are the most prevalent ocular symptoms in adults. [14] The most common ophthalmological findings include conjunctival irritation\u00a0followed by diplopia and cotton wool patches. [14]", "contents": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- Epidemiology. Among ocular manifestations of the disease, conjunctivitis and keratoconjunctivitis are the most prevalent ocular symptoms in adults. [14] The most common ophthalmological findings include conjunctival irritation\u00a0followed by diplopia and cotton wool patches. [14]"}
{"id": "article-96178_17", "title": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- Pathophysiology", "content": "The pathogenesis and tissue tropism of SARS-CoV-2\u00a0are linked to the interaction between the viral spike protein and its cognate receptor on human host cells\u2014 the angiotensin-converting enzyme 2 (ACE-2) receptor. Efficient cell entry requires cleavage by the protein transmembrane serine protease 2 (TMPRSS2). ACE-2 expression is predominant in respiratory mucosal and alveolar epithelial cells\u00a0but\u00a0has also been identified in other tissues, including the gastrointestinal tract, kidney, vascular endothelial cells, immune cells, and even neurons. Virulence is achieved\u00a0through direct cellular invasion and death and the induction of widespread cytokine-driven inflammation and vascular leakage. [15] Additionally, immune cell and complement debris\u00a0may contribute\u00a0to an increased thromboembolic state.", "contents": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- Pathophysiology. The pathogenesis and tissue tropism of SARS-CoV-2\u00a0are linked to the interaction between the viral spike protein and its cognate receptor on human host cells\u2014 the angiotensin-converting enzyme 2 (ACE-2) receptor. Efficient cell entry requires cleavage by the protein transmembrane serine protease 2 (TMPRSS2). ACE-2 expression is predominant in respiratory mucosal and alveolar epithelial cells\u00a0but\u00a0has also been identified in other tissues, including the gastrointestinal tract, kidney, vascular endothelial cells, immune cells, and even neurons. Virulence is achieved\u00a0through direct cellular invasion and death and the induction of widespread cytokine-driven inflammation and vascular leakage. [15] Additionally, immune cell and complement debris\u00a0may contribute\u00a0to an increased thromboembolic state."}
{"id": "article-96178_18", "title": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- Pathophysiology", "content": "The potential\u00a0for infection through ocular secretions is currently unknown, and\u00a0the mechanisms by which\u00a0SARS-CoV-2 accumulates in ocular secretions are not fully understood.\u00a0Several theories have been proposed, including direct inoculation of ocular tissues from respiratory droplets or aerosolized viral particles, migration from the nasopharynx\u00a0from the nasolacrimal duct, or even hematogenous spread through the lacrimal gland. [6]", "contents": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- Pathophysiology. The potential\u00a0for infection through ocular secretions is currently unknown, and\u00a0the mechanisms by which\u00a0SARS-CoV-2 accumulates in ocular secretions are not fully understood.\u00a0Several theories have been proposed, including direct inoculation of ocular tissues from respiratory droplets or aerosolized viral particles, migration from the nasopharynx\u00a0from the nasolacrimal duct, or even hematogenous spread through the lacrimal gland. [6]"}
{"id": "article-96178_19", "title": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- Pathophysiology", "content": "Data surrounding the expression of ACE-2 and TMPRSS2 on the ocular surface are varied. While a study\u00a0showed the presence of both\u00a0proteins on the cornea and limbus, low levels were noted in the conjunctiva. [16] Lange et al\u00a0similarly\u00a0reported low levels of ACE-2 in\u00a0the human conjunctiva. [17]", "contents": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- Pathophysiology. Data surrounding the expression of ACE-2 and TMPRSS2 on the ocular surface are varied. While a study\u00a0showed the presence of both\u00a0proteins on the cornea and limbus, low levels were noted in the conjunctiva. [16] Lange et al\u00a0similarly\u00a0reported low levels of ACE-2 in\u00a0the human conjunctiva. [17]"}
{"id": "article-96178_20", "title": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- Pathophysiology", "content": "A case report from Rome, Italy, documented the\u00a0isolation of SARS-CoV-2 by RT-PCR from conjunctival swabs in a patient with COVID-19 exhibiting ocular symptoms. [18] Conjunctival swabs were collected from the hospital on days 3\u00a0to\u00a027. Despite clinical resolution of conjunctivitis by day 20, the patient had detectable SARS-CoV-2 RNA in conjunctival samples on day 21 and subsequently on day 27, even after SARS-CoV-2 was\u00a0no longer detectable by nasopharyngeal swab.\u00a0Notably, the viability and transmissibility of\u00a0SARS-CoV-2 in human ocular secretions remain uncertain since the virus has not been successfully cultured from human tears or conjunctival swabs. [19] Limited reports suggest that tears can\u00a0serve as both an early and late source of infection transmission, even after the patient becomes asymptomatic. [18] [20]", "contents": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- Pathophysiology. A case report from Rome, Italy, documented the\u00a0isolation of SARS-CoV-2 by RT-PCR from conjunctival swabs in a patient with COVID-19 exhibiting ocular symptoms. [18] Conjunctival swabs were collected from the hospital on days 3\u00a0to\u00a027. Despite clinical resolution of conjunctivitis by day 20, the patient had detectable SARS-CoV-2 RNA in conjunctival samples on day 21 and subsequently on day 27, even after SARS-CoV-2 was\u00a0no longer detectable by nasopharyngeal swab.\u00a0Notably, the viability and transmissibility of\u00a0SARS-CoV-2 in human ocular secretions remain uncertain since the virus has not been successfully cultured from human tears or conjunctival swabs. [19] Limited reports suggest that tears can\u00a0serve as both an early and late source of infection transmission, even after the patient becomes asymptomatic. [18] [20]"}
{"id": "article-96178_21", "title": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- Pathophysiology", "content": "In a study by\u00a0Azzolini et al, SARS-CoV-2\u00a0was identified\u00a0on the ocular surface using RT-PCR in 52 of 91 patients with COVID-19 (57.1%). [5] The virus was\u00a0detected on the ocular surface in 10 of 17 patients, even when the nasopharyngeal swab\u00a0results were\u00a0negative.\u00a0Viral particles in tears\u00a0have been postulated\u00a0to originate from the lacrimal gland through diffusion from a systemic viral load or direct\u00a0contagion from airborne droplets. [5]", "contents": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- Pathophysiology. In a study by\u00a0Azzolini et al, SARS-CoV-2\u00a0was identified\u00a0on the ocular surface using RT-PCR in 52 of 91 patients with COVID-19 (57.1%). [5] The virus was\u00a0detected on the ocular surface in 10 of 17 patients, even when the nasopharyngeal swab\u00a0results were\u00a0negative.\u00a0Viral particles in tears\u00a0have been postulated\u00a0to originate from the lacrimal gland through diffusion from a systemic viral load or direct\u00a0contagion from airborne droplets. [5]"}
{"id": "article-96178_22", "title": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- History and Physical", "content": "The prevalence of ocular manifestations in patients with COVID-19 varies widely, ranging from 2% to 32% in reported studies. [21] [22] [23] These variations underscore the importance of ongoing research to understand better the frequency and nature of ocular involvement in patients with COVID-19.", "contents": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- History and Physical. The prevalence of ocular manifestations in patients with COVID-19 varies widely, ranging from 2% to 32% in reported studies. [21] [22] [23] These variations underscore the importance of ongoing research to understand better the frequency and nature of ocular involvement in patients with COVID-19."}
{"id": "article-96178_23", "title": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- History and Physical -- Conjunctiva", "content": "Individuals\u00a0infected with SARS-CoV-2 may present with acute conjunctivitis symptoms, including eye redness, ocular irritation, soreness, foreign body sensation, tearing, mucoid discharge, eyelid swelling, congestion, and\u00a0chemosis.\u00a0While these symptoms more commonly occur in patients with severe systemic symptoms of COVID-19, they can occasionally present as an initial manifestation of the disease. [12]", "contents": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- History and Physical -- Conjunctiva. Individuals\u00a0infected with SARS-CoV-2 may present with acute conjunctivitis symptoms, including eye redness, ocular irritation, soreness, foreign body sensation, tearing, mucoid discharge, eyelid swelling, congestion, and\u00a0chemosis.\u00a0While these symptoms more commonly occur in patients with severe systemic symptoms of COVID-19, they can occasionally present as an initial manifestation of the disease. [12]"}
{"id": "article-96178_24", "title": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- History and Physical -- Conjunctiva", "content": "Notably, unremitting conjunctivitis was\u00a0identified\u00a0as the sole manifestation of COVID-19 in 5 patients with confirmed SARS-CoV-2 infection through nasopharyngeal RT-PCR. These patients never developed fever, general malaise, or respiratory symptoms throughout their illness. [24]", "contents": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- History and Physical -- Conjunctiva. Notably, unremitting conjunctivitis was\u00a0identified\u00a0as the sole manifestation of COVID-19 in 5 patients with confirmed SARS-CoV-2 infection through nasopharyngeal RT-PCR. These patients never developed fever, general malaise, or respiratory symptoms throughout their illness. [24]"}
{"id": "article-96178_25", "title": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- History and Physical -- Conjunctiva", "content": "Examination findings\u00a0may include features\u00a0consistent with mild follicular conjunctivitis,\u00a0such as unilateral or bilateral bulbar conjunctiva injection, follicular reaction of the palpebral conjunctiva, watery discharge, and mild eyelid edema. Bilateral chemosis alone may represent third-spacing in a critically ill patient rather than a true ocular manifestation of the virus.", "contents": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- History and Physical -- Conjunctiva. Examination findings\u00a0may include features\u00a0consistent with mild follicular conjunctivitis,\u00a0such as unilateral or bilateral bulbar conjunctiva injection, follicular reaction of the palpebral conjunctiva, watery discharge, and mild eyelid edema. Bilateral chemosis alone may represent third-spacing in a critically ill patient rather than a true ocular manifestation of the virus."}
{"id": "article-96178_26", "title": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- History and Physical -- Conjunctiva", "content": "A case report by Cheema et al\u00a0documented the first keratoconjunctivitis as the presenting manifestation of COVID-19 in North America. [25] The patient primarily presented with symptoms\u00a0of eye redness and tearing. The examination revealed conjunctival injection,\u00a0a follicular reaction of the palpebral conjunctiva, and corneal findings that developed rapidly over\u00a03 days. These corneal findings included transient pseudodendritic lesions and diffuse subepithelial infiltrates with overlying epithelial defects.", "contents": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- History and Physical -- Conjunctiva. A case report by Cheema et al\u00a0documented the first keratoconjunctivitis as the presenting manifestation of COVID-19 in North America. [25] The patient primarily presented with symptoms\u00a0of eye redness and tearing. The examination revealed conjunctival injection,\u00a0a follicular reaction of the palpebral conjunctiva, and corneal findings that developed rapidly over\u00a03 days. These corneal findings included transient pseudodendritic lesions and diffuse subepithelial infiltrates with overlying epithelial defects."}
{"id": "article-96178_27", "title": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- History and Physical -- Conjunctiva", "content": "Severe hemorrhagic conjunctivitis and pseudomembrane formation\u00a0have also\u00a0manifested 19 days after the onset of COVID-19 systemic symptoms and 11 days after admission to the intensive care unit. [26] Notably,\u00a0in pediatric patients, COVID-19 has been strongly associated with the Kawasaki-like illness known as multisystem inflammatory syndrome in children (MIS-C). Several ocular manifestations, including papilledema, iritis, and keratitis,\u00a0have been reported in this syndrome, with conjunctivitis being the most prevalent ocular manifestation. [27]", "contents": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- History and Physical -- Conjunctiva. Severe hemorrhagic conjunctivitis and pseudomembrane formation\u00a0have also\u00a0manifested 19 days after the onset of COVID-19 systemic symptoms and 11 days after admission to the intensive care unit. [26] Notably,\u00a0in pediatric patients, COVID-19 has been strongly associated with the Kawasaki-like illness known as multisystem inflammatory syndrome in children (MIS-C). Several ocular manifestations, including papilledema, iritis, and keratitis,\u00a0have been reported in this syndrome, with conjunctivitis being the most prevalent ocular manifestation. [27]"}
{"id": "article-96178_28", "title": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- History and Physical -- Sclera/Episclera", "content": "Epsicleritis and scleritis are findings associated with COVID-19 infection. Unilateral and nodular episcleritis have been\u00a0observed at the onset of symptoms. [28] [29]", "contents": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- History and Physical -- Sclera/Episclera. Epsicleritis and scleritis are findings associated with COVID-19 infection. Unilateral and nodular episcleritis have been\u00a0observed at the onset of symptoms. [28] [29]"}
{"id": "article-96178_29", "title": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- History and Physical -- Sclera/Episclera", "content": "Necrotizing anterior scleritis can manifest as late as\u00a03 weeks after the onset of viral symptoms. [30] Moreover, sectoral anterior scleritis has been\u00a0reported up to 2 weeks after the onset of COVID-19, with noted improvement following treatment with topical and systemic steroids. [30]", "contents": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- History and Physical -- Sclera/Episclera. Necrotizing anterior scleritis can manifest as late as\u00a03 weeks after the onset of viral symptoms. [30] Moreover, sectoral anterior scleritis has been\u00a0reported up to 2 weeks after the onset of COVID-19, with noted improvement following treatment with topical and systemic steroids. [30]"}
{"id": "article-96178_30", "title": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- History and Physical -- Anterior Chamber", "content": "In addition to affecting the ocular surface, acute anterior uveitis has been reported independently and\u00a0associated\u00a0with COVID-19-related multisystem inflammatory disease. [31] [32] A\u00a0documented case of reactivated idiopathic anterior uveitis following COVID-19 infection has also been reported. Notably, this patient had remained quiescent for 13 years before\u00a0the occurrence of this episode. [33]", "contents": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- History and Physical -- Anterior Chamber. In addition to affecting the ocular surface, acute anterior uveitis has been reported independently and\u00a0associated\u00a0with COVID-19-related multisystem inflammatory disease. [31] [32] A\u00a0documented case of reactivated idiopathic anterior uveitis following COVID-19 infection has also been reported. Notably, this patient had remained quiescent for 13 years before\u00a0the occurrence of this episode. [33]"}
{"id": "article-96178_31", "title": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- History and Physical -- Retina and Choroid", "content": "Posterior segment diseases have also been suspected in association with COVID-19 infection, exhibiting diverse etiologies, including vascular, inflammatory, and neuronal involvement. Both ACE-2 and TMPRSS2 are\u00a0prominently expressed in the human retina. A recent case series\u00a0involving\u00a03 patients\u00a0identified S and N COVID-19 proteins\u00a0through immunofluorescence microscopy within retinal vascular endothelial cells,\u00a0suggesting the presence of\u00a0viral particles. [34] [35]", "contents": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- History and Physical -- Retina and Choroid. Posterior segment diseases have also been suspected in association with COVID-19 infection, exhibiting diverse etiologies, including vascular, inflammatory, and neuronal involvement. Both ACE-2 and TMPRSS2 are\u00a0prominently expressed in the human retina. A recent case series\u00a0involving\u00a03 patients\u00a0identified S and N COVID-19 proteins\u00a0through immunofluorescence microscopy within retinal vascular endothelial cells,\u00a0suggesting the presence of\u00a0viral particles. [34] [35]"}
{"id": "article-96178_32", "title": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- History and Physical -- Retina and Choroid", "content": "Reports of both\u00a0central retinal vein and artery occlusions have\u00a0emerged\u00a0in patients without typical systemic vascular risk factors. The hypothesized mechanism\u00a0involves a complement-induced prothrombic and inflammatory state induced by the virus, resulting in endothelial damage and microangiopathic injury. A striking example by Walinjkar et al\u00a0featured a central retinal vein occlusion in a 17-year-old female with COVID-19. [36] A similar case\u00a0was seen in a previously healthy 33-year-old individual. [37] Additionally, there have been multiple instances of\u00a0central retinal artery occlusions reported, potentially related to viral-induced endothelial insult and vasculitis. [38] [39] [40]", "contents": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- History and Physical -- Retina and Choroid. Reports of both\u00a0central retinal vein and artery occlusions have\u00a0emerged\u00a0in patients without typical systemic vascular risk factors. The hypothesized mechanism\u00a0involves a complement-induced prothrombic and inflammatory state induced by the virus, resulting in endothelial damage and microangiopathic injury. A striking example by Walinjkar et al\u00a0featured a central retinal vein occlusion in a 17-year-old female with COVID-19. [36] A similar case\u00a0was seen in a previously healthy 33-year-old individual. [37] Additionally, there have been multiple instances of\u00a0central retinal artery occlusions reported, potentially related to viral-induced endothelial insult and vasculitis. [38] [39] [40]"}
{"id": "article-96178_33", "title": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- History and Physical -- Retina and Choroid", "content": "Acute macular neuroretinopathy (AMN) and paracentral acute middle maculopathy (PAMM), conditions\u00a0characterized by ischemia in\u00a0the deep retinal capillary plexus, have been observed with COVID-19. Hyperreflective changes at the level of the outer plexiform and inner nuclear layers identify these conditions. [41]", "contents": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- History and Physical -- Retina and Choroid. Acute macular neuroretinopathy (AMN) and paracentral acute middle maculopathy (PAMM), conditions\u00a0characterized by ischemia in\u00a0the deep retinal capillary plexus, have been observed with COVID-19. Hyperreflective changes at the level of the outer plexiform and inner nuclear layers identify these conditions. [41]"}
{"id": "article-96178_34", "title": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- History and Physical -- Retina and Choroid", "content": "Purtscher-like retinopathy may manifest with findings of multiple bilateral cotton wool spots localized\u00a0to the posterior pole. This condition\u00a0typically occurs in patients with prolonged hospitalization\u00a0and\u00a0severe complications, including multiorgan failure and disseminated intravascular coagulation. [42] [43]", "contents": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- History and Physical -- Retina and Choroid. Purtscher-like retinopathy may manifest with findings of multiple bilateral cotton wool spots localized\u00a0to the posterior pole. This condition\u00a0typically occurs in patients with prolonged hospitalization\u00a0and\u00a0severe complications, including multiorgan failure and disseminated intravascular coagulation. [42] [43]"}
{"id": "article-96178_35", "title": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- History and Physical -- Retina and Choroid", "content": "Optical coherence tomography (OCT)\u00a0revealed\u00a0subclinical hyperreflective lesions at the inner plexiform and ganglion cell layer level in 12 adults examined after systemic disease onset. Additionally, cotton wool spots and microhemorrhages were\u00a0identified on dilated fundus examinations in 4 of these patients. [44] In a study by Invernizzi and colleagues, retinal findings such as hemorrhages (9.25%), cotton wools spots (7.4%), dilated veins (27.7%), and tortuous vessels (12.9%)\u00a0were observed\u00a0in 54 patients with COVID-19 upon screening\u00a0during fundus photography screening. [45]", "contents": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- History and Physical -- Retina and Choroid. Optical coherence tomography (OCT)\u00a0revealed\u00a0subclinical hyperreflective lesions at the inner plexiform and ganglion cell layer level in 12 adults examined after systemic disease onset. Additionally, cotton wool spots and microhemorrhages were\u00a0identified on dilated fundus examinations in 4 of these patients. [44] In a study by Invernizzi and colleagues, retinal findings such as hemorrhages (9.25%), cotton wools spots (7.4%), dilated veins (27.7%), and tortuous vessels (12.9%)\u00a0were observed\u00a0in 54 patients with COVID-19 upon screening\u00a0during fundus photography screening. [45]"}
{"id": "article-96178_36", "title": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- History and Physical -- Retina and Choroid", "content": "These authors also found\u00a0a direct correlation between\u00a0retinal vein diameter\u00a0and disease severity, suggesting that\u00a0monitoring retinal vein diameter could be a\u00a0noninvasive parameter\u00a0for\u00a0assessing the\u00a0inflammatory response or endothelial injury in COVID-19. Lecler et al\u00a0documented\u00a0abnormal MRI findings in the posterior pole of 9 patients with COVID-19 consisting of\u00a01 or several hyperintense nodules in the macular region on FLAIR-weighted images. [46] These lesions were postulated to be either direct inflammatory infiltration of the retina or microangiopathic disease\u00a0caused by viral infection.", "contents": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- History and Physical -- Retina and Choroid. These authors also found\u00a0a direct correlation between\u00a0retinal vein diameter\u00a0and disease severity, suggesting that\u00a0monitoring retinal vein diameter could be a\u00a0noninvasive parameter\u00a0for\u00a0assessing the\u00a0inflammatory response or endothelial injury in COVID-19. Lecler et al\u00a0documented\u00a0abnormal MRI findings in the posterior pole of 9 patients with COVID-19 consisting of\u00a01 or several hyperintense nodules in the macular region on FLAIR-weighted images. [46] These lesions were postulated to be either direct inflammatory infiltration of the retina or microangiopathic disease\u00a0caused by viral infection."}
{"id": "article-96178_37", "title": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- History and Physical -- Retina and Choroid", "content": "Various forms of posterior uveitis have been observed following either acute COVID-19 infection or administration of the COVID-19 vaccine. Souza et al reported a case of unilateral multifocal choroiditis,\u00a0although the temporal relationship of the viral infection could be attributed to chance alone. [47] Additionally, Goyal et al published a case of bilateral multifocal choroiditis within\u00a01 week of\u00a0receiving the COVID-19 vaccine. [48] Furthermore, cases of serpiginous and ampiginous choroiditis have also been reported. [49] [50]", "contents": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- History and Physical -- Retina and Choroid. Various forms of posterior uveitis have been observed following either acute COVID-19 infection or administration of the COVID-19 vaccine. Souza et al reported a case of unilateral multifocal choroiditis,\u00a0although the temporal relationship of the viral infection could be attributed to chance alone. [47] Additionally, Goyal et al published a case of bilateral multifocal choroiditis within\u00a01 week of\u00a0receiving the COVID-19 vaccine. [48] Furthermore, cases of serpiginous and ampiginous choroiditis have also been reported. [49] [50]"}
{"id": "article-96178_38", "title": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- History and Physical -- Retina and Choroid", "content": "Immune dysregulation\u00a0resulting from\u00a0COVID-19 infection may contribute to the reactivation of latent herpes virus, leading to acute retinal necrosis. [51] These cases highlight the importance of vigilance for potential viral reactivation and associated ocular complications in individuals with COVID-19.", "contents": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- History and Physical -- Retina and Choroid. Immune dysregulation\u00a0resulting from\u00a0COVID-19 infection may contribute to the reactivation of latent herpes virus, leading to acute retinal necrosis. [51] These cases highlight the importance of vigilance for potential viral reactivation and associated ocular complications in individuals with COVID-19."}
{"id": "article-96178_39", "title": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- History and Physical -- Retina and Choroid", "content": "Animal model studies have\u00a0demonstrated\u00a0the involvement of the retina in COVID-19 patients, revealing\u00a0retinal vasculitis, retinal degeneration, and breakdown of the blood-retinal barrier. [52] [53] [54] These findings provide valuable insights into the pathophysiology of\u00a0retinal complications associated with the virus.", "contents": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- History and Physical -- Retina and Choroid. Animal model studies have\u00a0demonstrated\u00a0the involvement of the retina in COVID-19 patients, revealing\u00a0retinal vasculitis, retinal degeneration, and breakdown of the blood-retinal barrier. [52] [53] [54] These findings provide valuable insights into the pathophysiology of\u00a0retinal complications associated with the virus."}
{"id": "article-96178_40", "title": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- History and Physical -- Optic Nerve", "content": "Various neuro-ophthalmologic manifestations have been\u00a0observed in association with COVID-19,\u00a0primarily related to demyelinating disease. While the mechanism of these manifestations is unclear, hypotheses include direct neuronal invasion, endothelial cell dysfunction leading to ischemia and coagulopathy, or a widespread inflammatory \"cytokine storm\" induced by the virus. [55] Optic neuritis has\u00a0been reported\u00a0in several patients with the infection, alongside neuromyelitis optica spectrum disorder and anti-myelin oligodendrocyte glycoprotein (anti-MOG) antibodies. [56] [57] [58]", "contents": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- History and Physical -- Optic Nerve. Various neuro-ophthalmologic manifestations have been\u00a0observed in association with COVID-19,\u00a0primarily related to demyelinating disease. While the mechanism of these manifestations is unclear, hypotheses include direct neuronal invasion, endothelial cell dysfunction leading to ischemia and coagulopathy, or a widespread inflammatory \"cytokine storm\" induced by the virus. [55] Optic neuritis has\u00a0been reported\u00a0in several patients with the infection, alongside neuromyelitis optica spectrum disorder and anti-myelin oligodendrocyte glycoprotein (anti-MOG) antibodies. [56] [57] [58]"}
{"id": "article-96178_41", "title": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- History and Physical -- Optic Nerve", "content": "Patients have presented with subacute vision loss, a relative afferent pupillary defect, pain with eye movements, optic disc edema, and radiographic findings of acute optic neuritis following COVID-19 infection. Additionally, there have been reports of acute optic neuritis following vaccination for COVID-19. [59]", "contents": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- History and Physical -- Optic Nerve. Patients have presented with subacute vision loss, a relative afferent pupillary defect, pain with eye movements, optic disc edema, and radiographic findings of acute optic neuritis following COVID-19 infection. Additionally, there have been reports of acute optic neuritis following vaccination for COVID-19. [59]"}
{"id": "article-96178_42", "title": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- History and Physical -- Optic Nerve", "content": "Palao et al reported a case of multiple sclerosis following COVID-19 infection in a 24-year-old patient who presented with right optic neuritis. MRI\u00a0revealed right optic nerve inflammation and supratentorial periventricular demyelinating lesions. [60] These cases suggest\u00a0a potential link between SARS-CoV-2\u00a0infection and the initiation or\u00a0exacerbation of inflammatory and demyelinating disease.", "contents": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- History and Physical -- Optic Nerve. Palao et al reported a case of multiple sclerosis following COVID-19 infection in a 24-year-old patient who presented with right optic neuritis. MRI\u00a0revealed right optic nerve inflammation and supratentorial periventricular demyelinating lesions. [60] These cases suggest\u00a0a potential link between SARS-CoV-2\u00a0infection and the initiation or\u00a0exacerbation of inflammatory and demyelinating disease."}
{"id": "article-96178_43", "title": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- History and Physical -- Optic Nerve", "content": "Ophthalmologists\u00a0should\u00a0be\u00a0consulted to\u00a0assess for papilledema in patients infected with SARS-CoV-2, as cases of elevated intracranial pressure have been reported. This elevation can stem from widespread inflammation and dural venous sinus thrombosis. [61] Furthermore,\u00a0MIS-C\u00a0associated\u00a0with COVID-19 is\u00a0increasingly\u00a0recognized as a\u00a0distinct syndrome similar to Kawasaki disease and has been linked to both optic neuritis and elevated intracranial pressure. [62]", "contents": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- History and Physical -- Optic Nerve. Ophthalmologists\u00a0should\u00a0be\u00a0consulted to\u00a0assess for papilledema in patients infected with SARS-CoV-2, as cases of elevated intracranial pressure have been reported. This elevation can stem from widespread inflammation and dural venous sinus thrombosis. [61] Furthermore,\u00a0MIS-C\u00a0associated\u00a0with COVID-19 is\u00a0increasingly\u00a0recognized as a\u00a0distinct syndrome similar to Kawasaki disease and has been linked to both optic neuritis and elevated intracranial pressure. [62]"}
{"id": "article-96178_44", "title": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- History and Physical -- Optic Nerve", "content": "Another example\u00a0involves a young patient who developed\u00a0pseudotumor cerebri syndrome associated with MIS-C due to COVID-19. The patient presented with a new right abducens palsy, papilledema with disc hemorrhages, and a lumbar puncture\u00a0revealing an opening pressure of 36 cm H2O. [63]", "contents": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- History and Physical -- Optic Nerve. Another example\u00a0involves a young patient who developed\u00a0pseudotumor cerebri syndrome associated with MIS-C due to COVID-19. The patient presented with a new right abducens palsy, papilledema with disc hemorrhages, and a lumbar puncture\u00a0revealing an opening pressure of 36 cm H2O. [63]"}
{"id": "article-96178_45", "title": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- History and Physical -- Extraocular Motility, Cranial Nerves", "content": "Cranial nerve III, IV, and VI palsies associated with COVID-19 have been reported in the literature, often occurring within a few days of fever and cough onset, with most cases lacking remarkable radiological features. [64] [65] [66] Ocular cranial neuropathies and binocular diplopia with nerve enhancement on MRI have also been observed in association with postinfectious demyelinating conditions such as Miller-Fisher and Guillain Barr\u00e9 syndromes. Presenting\u00a0signs\u00a0include\u00a0one-sided\u00a0mydriasis, ptosis, and limited depression and adduction\u00a0alongside concurrent MRI enhancement of the corresponding oculomotor nerve. [67] Lower extremity hyporeflexia and ataxia are also consistent with Miller-Fisher syndrome.", "contents": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- History and Physical -- Extraocular Motility, Cranial Nerves. Cranial nerve III, IV, and VI palsies associated with COVID-19 have been reported in the literature, often occurring within a few days of fever and cough onset, with most cases lacking remarkable radiological features. [64] [65] [66] Ocular cranial neuropathies and binocular diplopia with nerve enhancement on MRI have also been observed in association with postinfectious demyelinating conditions such as Miller-Fisher and Guillain Barr\u00e9 syndromes. Presenting\u00a0signs\u00a0include\u00a0one-sided\u00a0mydriasis, ptosis, and limited depression and adduction\u00a0alongside concurrent MRI enhancement of the corresponding oculomotor nerve. [67] Lower extremity hyporeflexia and ataxia are also consistent with Miller-Fisher syndrome."}
{"id": "article-96178_46", "title": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- History and Physical -- Extraocular Motility, Cranial Nerves", "content": "Ocular myasthenia gravis\u00a0is a postinfectious sequela of COVID-19, with researchers proposing that antibodies targeting SARS-CoV-2 proteins may cross-react with acetylcholine receptors and similar components at the neuromuscular junction. [68] The condition\u00a0can be\u00a0successfully managed with intravenous immunoglobulins and oral pyridostigmine. [69]", "contents": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- History and Physical -- Extraocular Motility, Cranial Nerves. Ocular myasthenia gravis\u00a0is a postinfectious sequela of COVID-19, with researchers proposing that antibodies targeting SARS-CoV-2 proteins may cross-react with acetylcholine receptors and similar components at the neuromuscular junction. [68] The condition\u00a0can be\u00a0successfully managed with intravenous immunoglobulins and oral pyridostigmine. [69]"}
{"id": "article-96178_47", "title": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- History and Physical -- Pupils", "content": "Patients with COVID-19 may exhibit pupillary changes such as mydriasis and cholinergic super-sensitivity, indicating tonic pupils and postganglionic parasympathetic pupillary nerve fiber damage. [70] [71] [72] These changes underscore the diverse neurological implications of SARS-CoV-2 infection.", "contents": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- History and Physical -- Pupils. Patients with COVID-19 may exhibit pupillary changes such as mydriasis and cholinergic super-sensitivity, indicating tonic pupils and postganglionic parasympathetic pupillary nerve fiber damage. [70] [71] [72] These changes underscore the diverse neurological implications of SARS-CoV-2 infection."}
{"id": "article-96178_48", "title": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- History and Physical -- Nystagmus", "content": "Visual disturbances such as oscillopsia\u00a0can be\u00a0observed in COVID-19 patients with neurologic involvement. Viral-induced vestibular neuritis can manifest as intractable vertigo, nausea, and vomiting. [73] Central vestibular nystagmus is also associated with clinical and imaging findings consistent with rhombencephalitis. [74] [75]", "contents": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- History and Physical -- Nystagmus. Visual disturbances such as oscillopsia\u00a0can be\u00a0observed in COVID-19 patients with neurologic involvement. Viral-induced vestibular neuritis can manifest as intractable vertigo, nausea, and vomiting. [73] Central vestibular nystagmus is also associated with clinical and imaging findings consistent with rhombencephalitis. [74] [75]"}
{"id": "article-96178_49", "title": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- History and Physical -- Visual Cortex", "content": "Perhaps the most devastating neuro-ophthalmic complication of severe COVID-19 infection is acute stroke affecting the posterior visual pathways.\u00a0Studies indicate that the incidence of stroke in these patients\u00a0is 7.6 times higher than that of patients with influenza, occurring in a notably younger-than-average patient population without classic vascular risk factors. [76] Patients may present with homonymous visual field deficits, prompting ophthalmologic consultation.\u00a0One example is a\u00a0recently published\u00a0case\u00a0involving a 12-year-old patient with MIS-C related to COVID-19, who presented with bilateral posterior cerebral artery ischemic strokes presenting as a homonymous visual field defect. [77]", "contents": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- History and Physical -- Visual Cortex. Perhaps the most devastating neuro-ophthalmic complication of severe COVID-19 infection is acute stroke affecting the posterior visual pathways.\u00a0Studies indicate that the incidence of stroke in these patients\u00a0is 7.6 times higher than that of patients with influenza, occurring in a notably younger-than-average patient population without classic vascular risk factors. [76] Patients may present with homonymous visual field deficits, prompting ophthalmologic consultation.\u00a0One example is a\u00a0recently published\u00a0case\u00a0involving a 12-year-old patient with MIS-C related to COVID-19, who presented with bilateral posterior cerebral artery ischemic strokes presenting as a homonymous visual field defect. [77]"}
{"id": "article-96178_50", "title": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- History and Physical -- Orbit and Ocular Adnexa", "content": "While oculoplastic and orbital manifestations of COVID-19 are rare,\u00a0emerging evidence suggests a potential association between the virus and inflammatory\u00a0or infectious disease. There have been\u00a02 reported cases of sinusitis, orbital cellulitis, and intracranial abnormalities in adolescents with COVID-19. [78]", "contents": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- History and Physical -- Orbit and Ocular Adnexa. While oculoplastic and orbital manifestations of COVID-19 are rare,\u00a0emerging evidence suggests a potential association between the virus and inflammatory\u00a0or infectious disease. There have been\u00a02 reported cases of sinusitis, orbital cellulitis, and intracranial abnormalities in adolescents with COVID-19. [78]"}
{"id": "article-96178_51", "title": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- History and Physical -- Orbit and Ocular Adnexa", "content": "This study hypothesized\u00a0that SARS-CoV-2 infection could result in congestion of the upper respiratory tract, increasing the risk\u00a0of secondary bacterial infection. This theory was expanded on by Shires et al, who\u00a0presented a case of bacterial orbital abscess in a patient with COVID-19. Notably, the intraoperative findings of highly avascular nasal mucosa and cultures\u00a0yielded Streptococcus constellatus and Peptonipihilus indolicus , bacteria ordinarily absent in the orbit or upper respiratory mucosa. [79] The local microbiologic and immunologic environment\u00a0could have been\u00a0altered due to avascularity induced by thrombosis in the setting of SARS-CoV-2 infection.", "contents": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- History and Physical -- Orbit and Ocular Adnexa. This study hypothesized\u00a0that SARS-CoV-2 infection could result in congestion of the upper respiratory tract, increasing the risk\u00a0of secondary bacterial infection. This theory was expanded on by Shires et al, who\u00a0presented a case of bacterial orbital abscess in a patient with COVID-19. Notably, the intraoperative findings of highly avascular nasal mucosa and cultures\u00a0yielded Streptococcus constellatus and Peptonipihilus indolicus , bacteria ordinarily absent in the orbit or upper respiratory mucosa. [79] The local microbiologic and immunologic environment\u00a0could have been\u00a0altered due to avascularity induced by thrombosis in the setting of SARS-CoV-2 infection."}
{"id": "article-96178_52", "title": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- History and Physical -- Orbit and Ocular Adnexa", "content": "A rising number of reports\u00a0have documented\u00a0acute invasive fungal rhino-orbital mucormycosis coinfection with COVID-19. These opportunistic pathogens thrive in the hypoxic respiratory environment induced by SARS-CoV-2 and an immunocompromised state induced by high-dose steroids and immunosuppressive therapies. The risk is further heightened in patients with poorly controlled diabetes, particularly those with diabetic ketoacidosis (DKA). [80] [81] [82]", "contents": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- History and Physical -- Orbit and Ocular Adnexa. A rising number of reports\u00a0have documented\u00a0acute invasive fungal rhino-orbital mucormycosis coinfection with COVID-19. These opportunistic pathogens thrive in the hypoxic respiratory environment induced by SARS-CoV-2 and an immunocompromised state induced by high-dose steroids and immunosuppressive therapies. The risk is further heightened in patients with poorly controlled diabetes, particularly those with diabetic ketoacidosis (DKA). [80] [81] [82]"}
{"id": "article-96178_53", "title": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- History and Physical -- Orbit and Ocular Adnexa", "content": "Singh et al\u00a0conducted a systematic review of 101 reported cases of COVID-19 patients with mucormycosis, revealing a predominantly male population (79%), with 80%\u00a0having diabetes and 15% with concomitant DKA. [83] Corticosteroids had been\u00a0administered\u00a0in 76% of these patients, and nearly 60% of the cases reported rhino-orbital involvement. [83] Notably, orbital compartment syndrome due to concurrent COVID-19 and fulminant mucormycotic infection can also occur. [84]", "contents": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- History and Physical -- Orbit and Ocular Adnexa. Singh et al\u00a0conducted a systematic review of 101 reported cases of COVID-19 patients with mucormycosis, revealing a predominantly male population (79%), with 80%\u00a0having diabetes and 15% with concomitant DKA. [83] Corticosteroids had been\u00a0administered\u00a0in 76% of these patients, and nearly 60% of the cases reported rhino-orbital involvement. [83] Notably, orbital compartment syndrome due to concurrent COVID-19 and fulminant mucormycotic infection can also occur. [84]"}
{"id": "article-96178_54", "title": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- History and Physical -- Orbit and Ocular Adnexa", "content": "There have also been reports of MRI-proven orbital myositis in\u00a02 separate COVID-19 patients\u00a0without\u00a0concurrent bacterial infection. [85] [86] The authors postulated that direct viral orbital invasion of the orbit or induced autoimmunity were possible mechanisms. Patients with positive SARS-CoV-2 antibodies can develop acute dacryoadenitis. Patients respond favorably to a slow taper of steroids over 6 weeks. [87]", "contents": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- History and Physical -- Orbit and Ocular Adnexa. There have also been reports of MRI-proven orbital myositis in\u00a02 separate COVID-19 patients\u00a0without\u00a0concurrent bacterial infection. [85] [86] The authors postulated that direct viral orbital invasion of the orbit or induced autoimmunity were possible mechanisms. Patients with positive SARS-CoV-2 antibodies can develop acute dacryoadenitis. Patients respond favorably to a slow taper of steroids over 6 weeks. [87]"}
{"id": "article-96178_55", "title": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- History and Physical -- Lacrimal System", "content": "Epiphora has been described as an initial finding in patients with COVID-19, believed to result from inflammation of the conjunctiva. [12] No reports have indicated direct involvement of the nasolacrimal system or the lacrimal sac in COVID-19.", "contents": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- History and Physical -- Lacrimal System. Epiphora has been described as an initial finding in patients with COVID-19, believed to result from inflammation of the conjunctiva. [12] No reports have indicated direct involvement of the nasolacrimal system or the lacrimal sac in COVID-19."}
{"id": "article-96178_56", "title": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- History and Physical -- Manifestations in Newborn Infants", "content": "Recent data support the occurrence of frequent ocular manifestations of SARS-CoV-2 infection in newborn infants. In a study by Perez-Chimal et al conducted in Mexico, 15 infants with positive RT-PCR nasopharyngeal swabs were identified. All of these newborns exhibited ocular manifestations, periorbital edema being the most common (100%), followed by chemosis and hemorrhagic conjunctivitis (73%) and ciliary injection (53%). Unique findings included corneal edema in 6 infants (40%), 1 with rubeosis and posterior synechiae, and posterior segment manifestations, including retinopathy of prematurity in 3 infants (20%). [88] Vitreous hemorrhage was observed in 1 full-term baby, and subtle cotton wool spots in 2 other newborns.", "contents": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- History and Physical -- Manifestations in Newborn Infants. Recent data support the occurrence of frequent ocular manifestations of SARS-CoV-2 infection in newborn infants. In a study by Perez-Chimal et al conducted in Mexico, 15 infants with positive RT-PCR nasopharyngeal swabs were identified. All of these newborns exhibited ocular manifestations, periorbital edema being the most common (100%), followed by chemosis and hemorrhagic conjunctivitis (73%) and ciliary injection (53%). Unique findings included corneal edema in 6 infants (40%), 1 with rubeosis and posterior synechiae, and posterior segment manifestations, including retinopathy of prematurity in 3 infants (20%). [88] Vitreous hemorrhage was observed in 1 full-term baby, and subtle cotton wool spots in 2 other newborns."}
{"id": "article-96178_57", "title": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- Evaluation", "content": "A thorough history\u00a0is\u00a0essential, including\u00a0details about the symptoms' onset, duration, and\u00a0nature. Examination of the anterior segment using a slit lamp or at the bedside can confirm findings of conjunctivitis or episcleritis. Additionally, measuring visual acuity and intraocular pressure and performing a dilated fundus examination are warranted to rule out potentially more\u00a0severe ocular diseases.", "contents": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- Evaluation. A thorough history\u00a0is\u00a0essential, including\u00a0details about the symptoms' onset, duration, and\u00a0nature. Examination of the anterior segment using a slit lamp or at the bedside can confirm findings of conjunctivitis or episcleritis. Additionally, measuring visual acuity and intraocular pressure and performing a dilated fundus examination are warranted to rule out potentially more\u00a0severe ocular diseases."}
{"id": "article-96178_58", "title": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- Evaluation", "content": "The examination should include a meticulous\u00a0assessment of the pupils and color testing to evaluate patients for evidence of optic neuropathy. Evaluation of extraocular motility may reveal evidence of nystagmus or cranial neuropathies. Additionally, visual field testing can detect and confirm deficits\u00a0associated with\u00a0stroke.", "contents": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- Evaluation. The examination should include a meticulous\u00a0assessment of the pupils and color testing to evaluate patients for evidence of optic neuropathy. Evaluation of extraocular motility may reveal evidence of nystagmus or cranial neuropathies. Additionally, visual field testing can detect and confirm deficits\u00a0associated with\u00a0stroke."}
{"id": "article-96178_59", "title": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- Evaluation", "content": "SARS-CoV-2 can be detected via reverse transcription polymerase chain reaction (RT-PCR) using a virus sampling swab to sweep the lower eyelid fornices\u00a0and collect tears and conjunctival secretions. [13] A conjunctival\u00a0swab is the gold standard for tear collection and viral testing. [14]", "contents": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- Evaluation. SARS-CoV-2 can be detected via reverse transcription polymerase chain reaction (RT-PCR) using a virus sampling swab to sweep the lower eyelid fornices\u00a0and collect tears and conjunctival secretions. [13] A conjunctival\u00a0swab is the gold standard for tear collection and viral testing. [14]"}
{"id": "article-96178_60", "title": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- Evaluation", "content": "Additional serum or cerebrospinal fluid testing may be helpful to evaluate for inflammatory, autoimmune, or demyelinating entities. Neuroimaging can also provide valuable information, especially in patients with optic neuritis, visual field deficits, cranial neuropathies, or other associated neurologic symptoms.", "contents": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- Evaluation. Additional serum or cerebrospinal fluid testing may be helpful to evaluate for inflammatory, autoimmune, or demyelinating entities. Neuroimaging can also provide valuable information, especially in patients with optic neuritis, visual field deficits, cranial neuropathies, or other associated neurologic symptoms."}
{"id": "article-96178_61", "title": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- Evaluation", "content": "All patients should be\u00a0queried about recent fever, respiratory symptoms, exposure, and travel history to\u00a0determine the need for further evaluation\u00a0for COVID-19.\u00a0This comprehensive assessment helps identify potential cases and ensure appropriate management and precautions.", "contents": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- Evaluation. All patients should be\u00a0queried about recent fever, respiratory symptoms, exposure, and travel history to\u00a0determine the need for further evaluation\u00a0for COVID-19.\u00a0This comprehensive assessment helps identify potential cases and ensure appropriate management and precautions."}
{"id": "article-96178_62", "title": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- Treatment / Management", "content": "Chen et al reported gradual symptomatic improvement of COVID-19 conjunctivitis in\u00a01 patient with the administration of ribavirin eye drops. [89] While the efficacy of targeted treatment remains unstudied, its long-term significance in a self-limited viral illness is unlikely. Nonetheless, eye care providers should be\u00a0cautious and aim to reduce\u00a0possible viral load and potential transmission. [90]", "contents": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- Treatment / Management. Chen et al reported gradual symptomatic improvement of COVID-19 conjunctivitis in\u00a01 patient with the administration of ribavirin eye drops. [89] While the efficacy of targeted treatment remains unstudied, its long-term significance in a self-limited viral illness is unlikely. Nonetheless, eye care providers should be\u00a0cautious and aim to reduce\u00a0possible viral load and potential transmission. [90]"}
{"id": "article-96178_63", "title": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- Treatment / Management", "content": "As with other viral infections, COVID-19 conjunctivitis is presumed to be self-limited and managed with symptomatic care. In the absence of significant eye pain, decreased vision, or light sensitivity, many patients can be managed remotely with a trial of frequent preservative-free artificial tears, cold compresses, and lubricating ophthalmic ointment. A short course of topical antibiotics may be considered to prevent or treat bacterial superinfection, especially in patients with symptoms and risk factors such as contact lens wear. [91]", "contents": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- Treatment / Management. As with other viral infections, COVID-19 conjunctivitis is presumed to be self-limited and managed with symptomatic care. In the absence of significant eye pain, decreased vision, or light sensitivity, many patients can be managed remotely with a trial of frequent preservative-free artificial tears, cold compresses, and lubricating ophthalmic ointment. A short course of topical antibiotics may be considered to prevent or treat bacterial superinfection, especially in patients with symptoms and risk factors such as contact lens wear. [91]"}
{"id": "article-96178_64", "title": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- Treatment / Management", "content": "On March 18, 2020, the American Academy of Ophthalmology (AAO) issued guidance urging all ophthalmologists to\u00a0prioritize\u00a0urgent or emergent care to\u00a0minimize the risk of SARS-CoV-2 transmission and conserve disposable medical supplies. They outlined specific criteria\u00a0for determining the necessity of care (see Table. AAO Risk Stratification for Clinic Ophthalmic Patients).", "contents": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- Treatment / Management. On March 18, 2020, the American Academy of Ophthalmology (AAO) issued guidance urging all ophthalmologists to\u00a0prioritize\u00a0urgent or emergent care to\u00a0minimize the risk of SARS-CoV-2 transmission and conserve disposable medical supplies. They outlined specific criteria\u00a0for determining the necessity of care (see Table. AAO Risk Stratification for Clinic Ophthalmic Patients)."}
{"id": "article-96178_65", "title": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- Treatment / Management", "content": "Although preliminary studies\u00a0indicate a low\u00a0risk of viral transmission through ocular secretions, comprehensive\u00a0large-scale research is lacking, and new data\u00a0continues to emerge\u00a0regularly. Therefore, healthcare providers are\u00a0strongly advised\u00a0to\u00a0maintain\u00a0proper protection of the eyes, nose, and mouth when examining patients. Given the nature and proximity of the ophthalmic examination, eye care providers and technicians may\u00a0face\u00a0increased susceptibility to infection. [92]", "contents": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- Treatment / Management. Although preliminary studies\u00a0indicate a low\u00a0risk of viral transmission through ocular secretions, comprehensive\u00a0large-scale research is lacking, and new data\u00a0continues to emerge\u00a0regularly. Therefore, healthcare providers are\u00a0strongly advised\u00a0to\u00a0maintain\u00a0proper protection of the eyes, nose, and mouth when examining patients. Given the nature and proximity of the ophthalmic examination, eye care providers and technicians may\u00a0face\u00a0increased susceptibility to infection. [92]"}
{"id": "article-96178_66", "title": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- Treatment / Management", "content": "Eye care providers should utilize slit lamp breath shields and\u00a0advise\u00a0patients to\u00a0minimize talking while seated at the slit lamp to minimize the risk of\u00a0virus transmission. Implementing rigorous disinfection and sterilization\u00a0protocols\u00a0for shared clinic equipment such as tonometers, trial frames, pinhole occluders, B-scan probes, and contact lenses for laser procedures is essential. [2] [92] Disposable barrier protection of clinic tools should be used where possible.", "contents": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- Treatment / Management. Eye care providers should utilize slit lamp breath shields and\u00a0advise\u00a0patients to\u00a0minimize talking while seated at the slit lamp to minimize the risk of\u00a0virus transmission. Implementing rigorous disinfection and sterilization\u00a0protocols\u00a0for shared clinic equipment such as tonometers, trial frames, pinhole occluders, B-scan probes, and contact lenses for laser procedures is essential. [2] [92] Disposable barrier protection of clinic tools should be used where possible."}
{"id": "article-96178_67", "title": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- Treatment / Management", "content": "If the patient exhibits 2 out of 3 of the symptoms noted above (see Table. AAO Risk Stratification for Clinic Ophthalmic Patients), they are referred for medical assessment. Patients with COVID-19 or symptoms such as fever, cough, or shortness of breath are examined in a separate isolation room. Ideally, only\u00a01 person (physician, technician, etc) should be present in the room due to the small size of ophthalmic rooms, and they should wear complete personal protective equipment (PPE), including a gown, N95 mask, face shield, and gloves. Hands\u00a0should be washed before and after examination for a minimum of 20 seconds with soap and water.\u00a0After the ophthalmic examination, the patient is\u00a0referred for further assessment by the medical team.", "contents": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- Treatment / Management. If the patient exhibits 2 out of 3 of the symptoms noted above (see Table. AAO Risk Stratification for Clinic Ophthalmic Patients), they are referred for medical assessment. Patients with COVID-19 or symptoms such as fever, cough, or shortness of breath are examined in a separate isolation room. Ideally, only\u00a01 person (physician, technician, etc) should be present in the room due to the small size of ophthalmic rooms, and they should wear complete personal protective equipment (PPE), including a gown, N95 mask, face shield, and gloves. Hands\u00a0should be washed before and after examination for a minimum of 20 seconds with soap and water.\u00a0After the ophthalmic examination, the patient is\u00a0referred for further assessment by the medical team."}
{"id": "article-96178_68", "title": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- Treatment / Management -- Protection of Medical Workers", "content": "While\u00a0the 2003 SARS-CoV crisis did not\u00a0lead to such widespread infection in the United States, healthcare workers accounted for about 20% of all patients with infections. [93] Recent data indicate\u00a0that\u00a0healthcare workers comprise 9% of COVID-10 cases in Italy.", "contents": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- Treatment / Management -- Protection of Medical Workers. While\u00a0the 2003 SARS-CoV crisis did not\u00a0lead to such widespread infection in the United States, healthcare workers accounted for about 20% of all patients with infections. [93] Recent data indicate\u00a0that\u00a0healthcare workers comprise 9% of COVID-10 cases in Italy."}
{"id": "article-96178_69", "title": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- Treatment / Management -- Protection of Medical Workers", "content": "Between March 2020 and April 7, 2021, over 3699 healthcare workers in the United States succumbed to COVID-19, with the majority being\u00a0younger\u00a0than 60 years. As of April 7, 2021, Italy had recorded 129,873 coronavirus cases among healthcare workers, with\u00a0over 100 healthcare workers, including over 60 doctors, having died from COVID-19 infections by April 2020. Current figures are unavailable, but the numbers in other countries\u00a0are expected to\u00a0increase.", "contents": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- Treatment / Management -- Protection of Medical Workers. Between March 2020 and April 7, 2021, over 3699 healthcare workers in the United States succumbed to COVID-19, with the majority being\u00a0younger\u00a0than 60 years. As of April 7, 2021, Italy had recorded 129,873 coronavirus cases among healthcare workers, with\u00a0over 100 healthcare workers, including over 60 doctors, having died from COVID-19 infections by April 2020. Current figures are unavailable, but the numbers in other countries\u00a0are expected to\u00a0increase."}
{"id": "article-96178_70", "title": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- Treatment / Management -- Protection of Medical Workers", "content": "Ensuring that frontline medical workers wear appropriate protective gear is crucial. Additionally, monitoring these healthcare workers for signs of disease and implementing appropriate containment measures is essential.", "contents": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- Treatment / Management -- Protection of Medical Workers. Ensuring that frontline medical workers wear appropriate protective gear is crucial. Additionally, monitoring these healthcare workers for signs of disease and implementing appropriate containment measures is essential."}
{"id": "article-96178_71", "title": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- Treatment / Management -- Protection of Medical Workers", "content": "A significant\u00a0number of deaths in the United States were\u00a0linked\u00a0to an initial severe shortage of appropriate PPE for healthcare providers. Even with the availability of PPE, selecting the level of protective gear based on the risk of infection is crucial. Suggestions are as follows: Ensure the waiting room maintains minimal occupancy, with available seating at least 6 feet apart. For patients who do not meet any of the 3 criteria mentioned above, healthcare workers\u00a0should wear a surgical mask, a face shield, and gloves and wash their\u00a0hands before and after each encounter. If a patient meets any of the\u00a03 criteria, healthcare workers must wear full PPE, including a gown, face shield, gloves, and N95 mask.", "contents": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- Treatment / Management -- Protection of Medical Workers. A significant\u00a0number of deaths in the United States were\u00a0linked\u00a0to an initial severe shortage of appropriate PPE for healthcare providers. Even with the availability of PPE, selecting the level of protective gear based on the risk of infection is crucial. Suggestions are as follows: Ensure the waiting room maintains minimal occupancy, with available seating at least 6 feet apart. For patients who do not meet any of the 3 criteria mentioned above, healthcare workers\u00a0should wear a surgical mask, a face shield, and gloves and wash their\u00a0hands before and after each encounter. If a patient meets any of the\u00a03 criteria, healthcare workers must wear full PPE, including a gown, face shield, gloves, and N95 mask."}
{"id": "article-96178_72", "title": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- Treatment / Management -- Protection of Medical Workers", "content": "Considering that droplets from sneezes can travel up to 6 meters, technicians from the Moran Eye Center have developed a slit-lamp shield using 2 plastic sheets through a laminator without paper in between, with openings cut for the eyepieces (see Image . Slit-Lamp Shield). [94] Others have\u00a0improvised using\u00a0old x-ray films\u00a0when commercial shields are in short supply. During consultations, conversations are kept to a minimum to reduce potential exposure. Some institutions, faced with a shortage of surgical masks, have explored options such as storing used masks for potential resterilization at the end of each day. Up to\u00a0a quarter of patients injected under sedation may\u00a0experience a severe involuntary sneeze, particularly common with eyelid injections. [95] [96] This is more common with eyelid injections than with retrobulbar injections. To mitigate this risk, ophthalmic surgeons must exercise caution and take appropriate precautions when administering a local anesthetic.", "contents": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- Treatment / Management -- Protection of Medical Workers. Considering that droplets from sneezes can travel up to 6 meters, technicians from the Moran Eye Center have developed a slit-lamp shield using 2 plastic sheets through a laminator without paper in between, with openings cut for the eyepieces (see Image . Slit-Lamp Shield). [94] Others have\u00a0improvised using\u00a0old x-ray films\u00a0when commercial shields are in short supply. During consultations, conversations are kept to a minimum to reduce potential exposure. Some institutions, faced with a shortage of surgical masks, have explored options such as storing used masks for potential resterilization at the end of each day. Up to\u00a0a quarter of patients injected under sedation may\u00a0experience a severe involuntary sneeze, particularly common with eyelid injections. [95] [96] This is more common with eyelid injections than with retrobulbar injections. To mitigate this risk, ophthalmic surgeons must exercise caution and take appropriate precautions when administering a local anesthetic."}
{"id": "article-96178_73", "title": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- Treatment / Management -- Surveillance\u00a0of Medical Workers", "content": "In Singapore, healthcare workers reported their temperatures twice a day via an online system, which proved to be a prudent approach. Conventional \"walk-by\" temperature testing may offer inaccurate or comprehensive results, particularly with staff arriving early or leaving late. [97] As of April 16, 2021, Singapore had recorded 60,769 infections and only 30 deaths attributable\u00a0to the virus.", "contents": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- Treatment / Management -- Surveillance\u00a0of Medical Workers. In Singapore, healthcare workers reported their temperatures twice a day via an online system, which proved to be a prudent approach. Conventional \"walk-by\" temperature testing may offer inaccurate or comprehensive results, particularly with staff arriving early or leaving late. [97] As of April 16, 2021, Singapore had recorded 60,769 infections and only 30 deaths attributable\u00a0to the virus."}
{"id": "article-96178_74", "title": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- Treatment / Management -- Surveillance\u00a0of Medical Workers", "content": "All travel outside the state or country should be declared to the medical administration for review. This\u00a0protocol remains relevant\u00a0given the ongoing occurrence of infection in various states and countries. Additionally, all healthcare workers should promptly self-report symptoms\u00a0to facilitate appropriate testing. Isolation and contact tracing\u00a0measures can\u00a0then be\u00a0implemented as necessary.", "contents": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- Treatment / Management -- Surveillance\u00a0of Medical Workers. All travel outside the state or country should be declared to the medical administration for review. This\u00a0protocol remains relevant\u00a0given the ongoing occurrence of infection in various states and countries. Additionally, all healthcare workers should promptly self-report symptoms\u00a0to facilitate appropriate testing. Isolation and contact tracing\u00a0measures can\u00a0then be\u00a0implemented as necessary."}
{"id": "article-96178_75", "title": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- Treatment / Management -- Sterilization of Equipment", "content": "After each patient, the slit-lamp shields are disinfected with 70% ethyl alcohol, as this concentration has been demonstrated to reduce coronavirus infectivity. [94] Slitlamps, B-scan probes, and other tools are cleaned\u00a0using 70% ethyl alcohol. Goldman tonometers undergo\u00a0sterilization with a 10% diluted sodium hypochlorite solution,\u00a0known to inactivate coronaviruses effectively. [98]", "contents": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- Treatment / Management -- Sterilization of Equipment. After each patient, the slit-lamp shields are disinfected with 70% ethyl alcohol, as this concentration has been demonstrated to reduce coronavirus infectivity. [94] Slitlamps, B-scan probes, and other tools are cleaned\u00a0using 70% ethyl alcohol. Goldman tonometers undergo\u00a0sterilization with a 10% diluted sodium hypochlorite solution,\u00a0known to inactivate coronaviruses effectively. [98]"}
{"id": "article-96178_76", "title": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- Differential Diagnosis", "content": "Ocular manifestations of COVID-19\u00a0often\u00a0present\u00a0with conjunctivitis,\u00a0which can resemble other\u00a0viral etiologies. Common ocular manifestations that should be considered in the differential diagnosis include the following: Viral conjunctivitis other than due to COVID-19 (eg, adenovirus) Bacterial conjunctivitis Allergic conjunctivitis Herpes simplex virus keratitis Anterior uveitis Corneal abrasion Foreign body Dry eye syndrome Exposure keratopathy in an intubated patient Chemosis in a critically ill patient", "contents": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- Differential Diagnosis. Ocular manifestations of COVID-19\u00a0often\u00a0present\u00a0with conjunctivitis,\u00a0which can resemble other\u00a0viral etiologies. Common ocular manifestations that should be considered in the differential diagnosis include the following: Viral conjunctivitis other than due to COVID-19 (eg, adenovirus) Bacterial conjunctivitis Allergic conjunctivitis Herpes simplex virus keratitis Anterior uveitis Corneal abrasion Foreign body Dry eye syndrome Exposure keratopathy in an intubated patient Chemosis in a critically ill patient"}
{"id": "article-96178_77", "title": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- Prognosis", "content": "Conjunctivitis related to COVID-19 is considered self-limited, but additional research is necessary to comprehend the lasting effects of other ocular manifestations associated with the virus. Studies examining SARS-CoV-2 detection in ocular samples\u00a0have\u00a0suggested\u00a0a potentially\u00a0poorer prognosis\u00a0for patients\u00a0who test positive for the virus in ocular specimens. [99]", "contents": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- Prognosis. Conjunctivitis related to COVID-19 is considered self-limited, but additional research is necessary to comprehend the lasting effects of other ocular manifestations associated with the virus. Studies examining SARS-CoV-2 detection in ocular samples\u00a0have\u00a0suggested\u00a0a potentially\u00a0poorer prognosis\u00a0for patients\u00a0who test positive for the virus in ocular specimens. [99]"}
{"id": "article-96178_78", "title": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- Prognosis", "content": "Upon further evaluation of the study cohort, it was found that patients with a higher viral load or greater severity of acute illness were more prone to testing positive for viral RNA in ocular samples. Additionally, they were more likely to have underlying comorbidities that\u00a0correlated with a poorer 10-year survival rate. [99]", "contents": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- Prognosis. Upon further evaluation of the study cohort, it was found that patients with a higher viral load or greater severity of acute illness were more prone to testing positive for viral RNA in ocular samples. Additionally, they were more likely to have underlying comorbidities that\u00a0correlated with a poorer 10-year survival rate. [99]"}
{"id": "article-96178_79", "title": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- Prognosis", "content": "The authors conclude that while ocular manifestations of COVID-19 do not\u00a0indicate decreased survival, they may\u00a0serve as a prognostic sign and a potential indicator of disease progression from moderate to\u00a0severe. [99] Further studies are\u00a0required to\u00a0assess this relationship more comprehensively.", "contents": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- Prognosis. The authors conclude that while ocular manifestations of COVID-19 do not\u00a0indicate decreased survival, they may\u00a0serve as a prognostic sign and a potential indicator of disease progression from moderate to\u00a0severe. [99] Further studies are\u00a0required to\u00a0assess this relationship more comprehensively."}
{"id": "article-96178_80", "title": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- Prognosis", "content": "Clinical data\u00a0indicates the possibility of the virus spreading through tear samples of infected patients is low. [100] In a recent case series, only 1 out of 30 confirmed cases of COVID-19 illness had positive tear samples.\u00a0Similarly, in another\u00a0study where tear samples and nasopharyngeal swabs were tested simultaneously, nasopharyngeal swabs tested positive without any positive tear samples. [100] However, despite these findings, a review of currently available data suggests that transmission through the eyes is plausible, as\u00a0evidenced by viral RNA isolation from COVID-19 patients with high-viral loads and active conjunctivitis. [101]", "contents": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- Prognosis. Clinical data\u00a0indicates the possibility of the virus spreading through tear samples of infected patients is low. [100] In a recent case series, only 1 out of 30 confirmed cases of COVID-19 illness had positive tear samples.\u00a0Similarly, in another\u00a0study where tear samples and nasopharyngeal swabs were tested simultaneously, nasopharyngeal swabs tested positive without any positive tear samples. [100] However, despite these findings, a review of currently available data suggests that transmission through the eyes is plausible, as\u00a0evidenced by viral RNA isolation from COVID-19 patients with high-viral loads and active conjunctivitis. [101]"}
{"id": "article-96178_81", "title": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- Complications", "content": "Most of the information regarding ocular manifestations of COVID-19 illness\u00a0comes from\u00a0small prospective cohorts or case studies.\u00a0While most suggest self-limited disease, the long-term prognosis and complication rate\u00a0remain\u00a0to be determined. However, some studies indicate that\u00a0mucormycosis may occur in these patients due to the immune dysregulation caused by COVID-19 infection and corticosteroid use for its treatment, especially in those with diabetes mellitus. [102]", "contents": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- Complications. Most of the information regarding ocular manifestations of COVID-19 illness\u00a0comes from\u00a0small prospective cohorts or case studies.\u00a0While most suggest self-limited disease, the long-term prognosis and complication rate\u00a0remain\u00a0to be determined. However, some studies indicate that\u00a0mucormycosis may occur in these patients due to the immune dysregulation caused by COVID-19 infection and corticosteroid use for its treatment, especially in those with diabetes mellitus. [102]"}
{"id": "article-96178_82", "title": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- Complications", "content": "Compromised tear film quality, which has been reported as another potential complication of COVID-19 illness, can lead to dry eye syndrome and ocular surface damage, especially in hospitalized patients. [99] Prompt recognition and management of ocular complications, including dry eye syndrome, in patients with COVID-19 are essential to prevent long-term ocular sequelae and improve overall patient comfort and well-being.", "contents": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- Complications. Compromised tear film quality, which has been reported as another potential complication of COVID-19 illness, can lead to dry eye syndrome and ocular surface damage, especially in hospitalized patients. [99] Prompt recognition and management of ocular complications, including dry eye syndrome, in patients with COVID-19 are essential to prevent long-term ocular sequelae and improve overall patient comfort and well-being."}
{"id": "article-96178_83", "title": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- Deterrence and Patient Education", "content": "Prevention strategies\u00a0remain vital\u00a0in\u00a0controlling disease\u00a0transmission, emphasizing physical distancing,\u00a0regular hand-washing, and minimizing direct touching of the eyes and face. Despite the availability of vaccines and declining infection rates in certain regions, these measures remain essential to curb the potential resurgence of COVID-19 and other infectious diseases. Other\u00a0recommendations to consider\u00a0include the following: Avoiding the use of contact lenses Limiting the application of cosmetics around the eye Opting for glasses\u00a0or sunglasses Regularly changing sheets, pillowcases, and towels\u00a0to maintain cleanliness and hygiene", "contents": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- Deterrence and Patient Education. Prevention strategies\u00a0remain vital\u00a0in\u00a0controlling disease\u00a0transmission, emphasizing physical distancing,\u00a0regular hand-washing, and minimizing direct touching of the eyes and face. Despite the availability of vaccines and declining infection rates in certain regions, these measures remain essential to curb the potential resurgence of COVID-19 and other infectious diseases. Other\u00a0recommendations to consider\u00a0include the following: Avoiding the use of contact lenses Limiting the application of cosmetics around the eye Opting for glasses\u00a0or sunglasses Regularly changing sheets, pillowcases, and towels\u00a0to maintain cleanliness and hygiene"}
{"id": "article-96178_84", "title": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- Pearls and Other Issues", "content": "Key facts to keep in mind regarding ophthalmic manifestations of COVID-19 include the following: Ocular shedding of SARS-CoV-2 through tears is a potential concern for ophthalmologists. Conjunctivitis or tearing may be some patients' initial or sole presentation of COVID-19. Several ocular manifestations of COVID-19 have been observed, including retinovascular disease, uveitis, optic neuropathies, and orbital fungal coinfections (see Image. Fungal Endophthalmitis). SARS-CoV-2 may trigger or exacerbate inflammatory/demyelinating disease. In advanced cases, patients may present with chemosis (see Image. Chemosis) or follicular conjunctivitis (see Image. Follicular Conjunctivitis). During ocular examinations, precautions such as wearing gloves and using extension instruments (eg, cotton swabs) should be taken to minimize direct contact with secretions.", "contents": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- Pearls and Other Issues. Key facts to keep in mind regarding ophthalmic manifestations of COVID-19 include the following: Ocular shedding of SARS-CoV-2 through tears is a potential concern for ophthalmologists. Conjunctivitis or tearing may be some patients' initial or sole presentation of COVID-19. Several ocular manifestations of COVID-19 have been observed, including retinovascular disease, uveitis, optic neuropathies, and orbital fungal coinfections (see Image. Fungal Endophthalmitis). SARS-CoV-2 may trigger or exacerbate inflammatory/demyelinating disease. In advanced cases, patients may present with chemosis (see Image. Chemosis) or follicular conjunctivitis (see Image. Follicular Conjunctivitis). During ocular examinations, precautions such as wearing gloves and using extension instruments (eg, cotton swabs) should be taken to minimize direct contact with secretions."}
{"id": "article-96178_85", "title": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- Pearls and Other Issues", "content": "Given that many ophthalmic clinic visitors are\u00a0older\u00a0and have underlying health conditions, careful screening for the necessity of in-person visits is crucial. Telemedicine is a viable alternative for non-urgent cases. Implementing social distancing measures within clinical settings can be challenging. Still, efforts should be made to limit the number of individuals in examination rooms, with a preference for only\u00a01 person accompanying the patient. Certain medical specialties, such as ophthalmology, otolaryngology, and anesthesiology, may face increased infection risks due to close proximity to mucosal surfaces during examinations or procedures. Surgical protocols, including delaying entry into operating rooms after intubation or extubation, aim to reduce transmission risks regardless of the patient's COVID-19 status.", "contents": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- Pearls and Other Issues. Given that many ophthalmic clinic visitors are\u00a0older\u00a0and have underlying health conditions, careful screening for the necessity of in-person visits is crucial. Telemedicine is a viable alternative for non-urgent cases. Implementing social distancing measures within clinical settings can be challenging. Still, efforts should be made to limit the number of individuals in examination rooms, with a preference for only\u00a01 person accompanying the patient. Certain medical specialties, such as ophthalmology, otolaryngology, and anesthesiology, may face increased infection risks due to close proximity to mucosal surfaces during examinations or procedures. Surgical protocols, including delaying entry into operating rooms after intubation or extubation, aim to reduce transmission risks regardless of the patient's COVID-19 status."}
{"id": "article-96178_86", "title": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- Enhancing Healthcare Team Outcomes", "content": "In outpatient, inpatient, and surgical settings, effective management of COVID-19 patients and containment of the disease require an interprofessional approach. Clear communication among hospital administration, provider teams, and clinic support staff is essential to establish expectations for patient screening, proper utilization of PPE, and integration of telemedicine technologies for consultations.", "contents": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- Enhancing Healthcare Team Outcomes. In outpatient, inpatient, and surgical settings, effective management of COVID-19 patients and containment of the disease require an interprofessional approach. Clear communication among hospital administration, provider teams, and clinic support staff is essential to establish expectations for patient screening, proper utilization of PPE, and integration of telemedicine technologies for consultations."}
{"id": "article-96178_87", "title": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- Enhancing Healthcare Team Outcomes", "content": "Identifying ocular manifestations of COVID-19 is crucial for early detection and effective management of patients with this disease. Therefore, all interprofessional healthcare team members (physicians, optometrists, advanced care practitioners, nurses, pharmacists) and other ancillary medical staff should be well-informed about these manifestations. Team members should feel empowered to raise concerns if they notice signs or symptoms suggestive of ocular involvement in a patient. Early recognition enables prompt intervention and contributes to improved patient outcomes. With close collaboration, healthcare professionals can enhance patient-centered care, promote patient safety, and optimize team performance in managing ophthalmic manifestations of COVID-19.", "contents": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- Enhancing Healthcare Team Outcomes. Identifying ocular manifestations of COVID-19 is crucial for early detection and effective management of patients with this disease. Therefore, all interprofessional healthcare team members (physicians, optometrists, advanced care practitioners, nurses, pharmacists) and other ancillary medical staff should be well-informed about these manifestations. Team members should feel empowered to raise concerns if they notice signs or symptoms suggestive of ocular involvement in a patient. Early recognition enables prompt intervention and contributes to improved patient outcomes. With close collaboration, healthcare professionals can enhance patient-centered care, promote patient safety, and optimize team performance in managing ophthalmic manifestations of COVID-19."}
{"id": "article-96178_88", "title": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- Review Questions", "content": "Access free multiple choice questions on this topic. Comment on this article.", "contents": "Ophthalmic Manifestations of Coronavirus (COVID-19) -- Review Questions. Access free multiple choice questions on this topic. Comment on this article."}